欢迎光临源叶生物,登录 | 注册 |
当前位置: 首页 > 小分子抑制剂 > Angiogenesis > CNX-2006

浏览历史

S80307

CNX-2006

源叶(MedMol) ≥98%
  • 英文名:
  • N-[3-[[2-[[4-[[1-(2-Fluoroethyl)-3-azetidinyl]amino]-2-methoxyphenyl]amino]-5-(trifluoromethyl)-4-py
  • 别名:
  • CNX 2006,CNX2006
  • CAS号:
  • 1375465-09-0
  • 分子式:
  • C26H27F4N7O2
  • 分子量:
  • 545.53
品牌货号产品规格价格(RMB) 库存(上海) 北京 武汉 南京 数量计量单位 加入购物车...
源叶(MedMol) S80307-5mg ≥98% ¥890.00元 6 - - - EA 加入购物车
源叶(MedMol) S80307-10mg ≥98% ¥1330.00元 6 - - - EA 加入购物车
源叶(MedMol) S80307-25mg ≥98% ¥2610.00元 5 - - - EA 加入购物车
源叶(MedMol) S80307-50mg ≥98% ¥3810.00元 1 - - - EA 加入购物车
源叶(MedMol) S80307-100mg ≥98% ¥7200.00元 2 - - - EA 加入购物车
源叶(MedMol) S80307-250mg ≥98% ¥14419.00元 2 - - - EA 加入购物车
大包装询价

提交您的电话号码并同意《个人信息授权与保护申明》,到货后将短信提示。
提交

产品介绍

参考文献

质检证书(COA)

摩尔浓度计算器

相关产品

  • 提示:详情请下载说明书。
  • 产品描述: CNX-2006 is a novel irreversible mutant-selective EGFR inhibitor with IC50 of < 20 nM, with very weak inhibition at wild-type EGFR.
  • 靶点: CNX-2006 is a mutant-selective and irreversible EGFR inhibitor with an IC50 below 20 nM for EGFRT790M.;EGFR
  • 体外研究:
    CNX-2006 inhibits EGFR-T790M cells growth up to 1000-fold more compared to wild-type EGFR cells. EGFR inhibition is observed in cells harbouring the T790M mutation at IC50 values below 20 nM after 1 hour exposure to the drug. CNX-2006 also significantly reduces the volume of tumor spheres derived from H1975 cells. CNX-2006 exhibits specificity and potent activity against T790M. The drug also shows activity against uncommon EGFR mutations including G719S, L861Q, an exon 19 insertion mutant (I744-K745insKIPVAI), and T854A, but not an exon 20 insertion (H773-V774HVdup). In an in vitro resistance model, CNX-2006 significantly inhibits the emergence of resistant cells. Chronic exposure to escalating doses of CNX-2006 fails to select for and/or enhance T790M-mediated resistance using PC-9 or HCC827 cells (both harboring exon 19 deletions), or PC-9/ER and HCC827/ER cells with existing T790M and resistance to erlotinib.
  • 体内研究:
    CNX-2006 is effective in H1975 (EGFR L858R/T790M) xenograft model.
  • 细胞实验: Cells with endogenous or transiently transfected mutant EGFRs (293 cells) are treated with inhibitors for 6 hours and then corresponding lysates are extracted and analyzed by immunoblotting.(Only for Reference)
  • 动物实验: Animal Models: Nude miceFormulation: 5% DMSO:15% Solutol HS15 in PBSDosages: 25 mg/kgAdministration: i.p.
  • 参考文献:
    1. Ohashi K, et al. 2013
  • 溶解性: soluble  in  DMSO、DMF
  • 保存条件: -20°C
  • 配置溶液浓度参考:
    1mg 5mg 10mg
    1 mM 1.833 ml 9.165 ml 18.331 ml
    5 mM 0.367 ml 1.833 ml 3.666 ml
    10 mM 0.183 ml 0.917 ml 1.833 ml
    50 mM 0.037 ml 0.183 ml 0.367 ml
  • 注意:部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。
输入产品批号:

本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:


质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)


  • =
    *
    *


源叶所有产品仅用作科学研究,销售产品行为均适用于我司网上所列通用销售条款。